Thomas Karikari wins excellence award for Alzheimer’s blood test discovery

Ghanaian neuroscientist Dr. Thomas Karikari has been honored with the Excellence in Scientific Research award at the Millennium Excellence Awards held in Washington, DC. An associate professor at the University of Pittsburgh, Dr. Karikari was recognized for his groundbreaking work in developing non-invasive blood tests for the early detection of Alzheimer’s disease. This innovation represents a significant shift in medical diagnostics, offering a simpler and more accessible alternative to traditional, more invasive testing methods.

Dr. Karikari’s research focuses on identifying biomarkers in the blood that can accurately signal the onset of Alzheimer's. Despite early skepticism within the scientific community regarding the feasibility of blood-based diagnostics for neurodegenerative diseases, his persistence has led to the publication of approximately 300 research papers and the acquisition of multiple patents. His contributions reached a major milestone recently with the United States Food and Drug Administration (FDA) approving two new blood tests based on his findings, which are expected to revolutionize how the disease is managed globally.

Beyond his academic success in the United States, Dr. Karikari is committed to addressing health disparities in his home country. He has announced plans to establish a specialized research center in Ghana dedicated to advancing biomedical research and improving diagnostic access in low-resource settings. By bringing this technology to Ghana, he aims to ensure that underserved communities can benefit from advanced medical screening, potentially transforming the landscape of neurological health and geriatric care across the region.